Immune System features Open Access original research and reviews reporting on translational and clinical studies encompassing all the field of immunology, bridging clinical with preclinical, and translational investigations. The journal emphasizes evidence-based clinical and laboratory research with statistically valid results that clearly help advancing our knowledge in the field. It specifically welcomes intra and inter disciplinarity Environmental immunology, Immunomics, Immunoterapy and including but not restricted to immune aspects of allergy, disorders of the respiratory tract, skin and autoimmune and neurodegenerative disorders. It encompasses original randomized controlled trials, as well as real-world evidence studies, reviews, systematic reviews, but also well-elaborated clinical cases and case-series could be acceptable. The transfer of information from fundamental research to clinical research and clinical practice is particularly welcome. Contributions and ideas from large segments of the scientific community are welcome to make Immune System a viable, much needed, and up-and-coming forum for current basic and applied immunological research.
Immunity is a monthly journal which publishes research articles and reviews of general interest in the entire discipline of immunology. Immunity was founded in the belief that advances in molecular and cellular immunology have brought immunology to a point at which a journal of high quality should be able to provide a unifying intellectual view, but the mandate for Immunity is not restricted to any particular level of analysis or to any particular type of system. The title Immunity is meant to indicate a breadth of interest extending beyond the formal definition of immunology, and into all systems that contribute to, or interact with, the immune system of the organism. Submitted articles are reviewed for both technical excellence and general interest, and those that are accepted are published within ten weeks.Immunity follows the example ofCell in defining criteria for general interest that are just as important as technical quality in deciding on the acceptability of submissions. The area of interest is defined broadly beyond the obvious characterization of immune genes and cells, effectively including any and all research that contributes to understanding of infection and host defenses. Practical consequences for clinical work are taken into account equally with advances in fundamental understanding.Visit the Immunity website to find out more - http://www.immunity.com .
Immunity, Inflammation and Disease is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research across the broad field of immunology. Immunity, Inflammation and Disease gives rapid consideration to papers in all areas of clinical and basic research. The journal is indexed in Medline and welcomes original work that enhances the understanding of immunology in areas including:
• cellular and molecular immunology
• clinical immunology
• allergy
• immunochemistry
• immunogenetics
• immune signalling
• immune development
• imaging
• mathematical modelling
• autoimmunity
• transplantation immunology
• cancer immunology
Original research articles, methods papers, editorials and commentaries are published. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper. Immunity, Inflammation and Disease considers for publication both papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley-Blackwell. List available here.
In order for research to advance, negative results, which often make a valuable contribution to the field, should be published. However, articles containing negative or null results are frequently not considered for publication or rejected by journals. We welcome papers of this kind, where appropriate and valid power calculations are included that give confidence that a negative result can be relied upon.
Keywords: immunology, imaging, allergy, autoimmunity
An international team of editors and scientific advisors maintains the high standard of quality set by Immunobiology since it first appeared in 1909. With contributions by prominent experts in the field, the journal is a focal point of scientific interest. Published research findings are a vital link between scientists and clinicians active at the experimental levels of immunobiology, serology, hematology, allergy, infectious diseases, transplantation, and nonspecific resistance. A new fast track line for high priority publications will speed up communication between scientists all over the world. Immunobiology, the world's first immunological journal, carries on the tradition set by such distinguished scientists as Carl Oluf Jensen, Sibasaburo Kitasato, Karl Landsteiner, Max Neisser and others.
While each volume of Immunological Reviews is devoted to a single topic of immunological research, collectively their aim is to provide a broad and continously updated survey of advances in basic immunology and their clinical applications.
Recognised as one of the leading journals in its fieldOne of the longest established immunology journalsImpact factor 3.674Wide trans-continental representation in authors. editors and reviewersRapid publication with thorough peer-reviewNo page charges for authors#r#r#r#r#r Immunologypublishes papers on fundamental aspects of immunology including:#r#r#r#r#rCellular immunologyInnate immunityMolecular immunologyAntigen presentationLymphocyte migrationImmunogeneticsImaging at the molecular. cellular or whole animal levelProtein crystallographyPlasmon resonanceIn silico modelingKnockout and knock-in studies#r#r#r#r#rOriginal articles describing mechanistic insights to the immune system are particularly welcome.The journal also publishes commissioned review articles on subjects of topical interest to immunologists. The editors are also prepared to consider unsolicited review suggestions in the form of submitted Abstracts.Immunologyis essential reading for workers in all areas of immunological research.#r#r#r#r#r #r#r#r#r#rAims and Scope#r#r#r#r#rRecognised as one of the leading journals in its fieldOne of the longest established immunology journalsImpact factor 3.398Wide trans-continental representation in authors. editors and reviewers#r#r#r#r#r Immunologypublishes papers on fundamental aspects of immunology including:#r#r#r#r#rCellular immunologyInnate immunityMolecular immunologyAntigen presentationLymphocyte migrationImmunogeneticsImaging at the molecular. cellular or whole animal levelProtein crystallographyPlasmon resonanceIn silico modelingKnockout and knock-in studies#r#r#r#r#rOriginal articles describing mechanistic insights to the immune system are particularly welcome.#r#r#r#r#rThe journal also publishes commissioned review articles on subjects of topical interest to immunologists. The editors are also prepared to consider unsolicited review suggestions in the form of submitted Abstracts.#r#r#r#r#rImmunologyis essential reading for workers in all areas of immunological research.#r#r#r#r#rFree Access in the Developing World#r#r#r#r#rFree online access to this journal is available within institutions in the developing world through theHINARIinitiative with the World Health Organization (WHO). and theAGORAinitiative with the Food and Agriculture Organization of the United Nations (FAO).#r#r#r#r#rOnlineOpen#r#r#r#r#rAuthors of articles in this journal can now choose to make their articles open access and available free for all readers through the payment of an author fee.Read more.#r#r#r#r#rReadership#r#r#r#r#rImmunologyprovides a sound advertising medium for related laboratory and pharmaceutical products. See Aims and Scope for more details. The readership includes research workers. university and college lecturers and clinical researchers (approx 80%); and laboratory technicians (20%).
mmunology & Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology.Areas that are covered include but are not limited to: * Cellular immunology * Innate and adaptive immunity * Immune responses to pathogens * Tumour immunology * Immunopathology * Immunotherapy * Immunogenetics * Immunological studies in humans and model organisms (including mouse, rat, Drosophila etc)This leading journal has an established international reputation, built on more than 85 years of innovative publishing. The Journal publishes peer-reviewed Original Articles, Short Communications and Outstanding Observation Articles that describe new research results. Outstanding Observation Articles describe striking reproducible observations that have extremely important conceptual implications but do not necessarily include insights into the underlying molecular mechanism. This manuscript category allows publication of extraordinary findings soon after their discovery. Methodological papers or technical reports of high quality will also be considered for publication as Original Articles or Short Communications. Immunology & Cell Biology also publishes Reviews and News and Commentary articles, which provide succinct summaries of, respectively, an area or a specific research advance in immunology. Landmark articles are brief commentaries which highlight the historical significance of a particular piece of research relevant to the journal's scope. Editorial articles are brief comments written by the editor(s) of the journal or by guest editor(s) of Special Features (see below) based on the contents of the current issue or topical subjects that fall within the scope of the journal. Immunology & Cell Biology occasionally publishes Meeting Reports that briefly detail the discussions, presentations and events at a relevant recent meeting.
Immunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings.Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.Special issues:Suggestions for special issue topics and guest editors can be sent to Deirdre Dunne, d.dunne@elsevier.comBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Immunology and Allergy Clinics of North America updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in immunology and allergy and is presented under the direction of an experienced guest editor. Topics include allergens, immunotherapy, anaphylaxis, asthma, drug allergy, eosinophilrelated disorders, food allergy, immunodeficiency states (non-HIV), basic science, mast cell disorders, rhinitis and sinusitis, and urticaria and angioedema.Immunology and Allergy Clinics of North America is published four times each year, in February, May, August, and November.
he journal Immunopharmacology and Immunotoxicology is devoted to preclinical and clinical studies about the regulatory effects of various agents on immunocompetent cells as well as the immunotoxicity exerted by xenobiotics and drugs. On these bases, the journal encompasses a broad range of pathologies (e.g., acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation and primary and secondary immunodeficiencies).In this framework, the journal will cover new emerging areas of science of broad interest, such as agricultural biotechnology; atherosclerosis; cytokine and growth factor regulation; dendritic cell therapy; food immunology and safety; forensic immunopathology; innate immunity regulation; microbial immunomodulators; mucosal immunity; drug development; psychoneuroimmunology; stem cell therapy; veterinary immunopathology; and vaccines. While articles related to purified extracts may be considered, research on crude botanical extracts are discouraged.Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, invited reviews, and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).Read More: http://informahealthcare.com/page/ipi/Description.
Immunotherapy offers the scientific community an interdisciplinary forum, providing them with the most recent advances of various aspects of immunotherapeutics to aid navigation of this complex field. Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research
Inflammation presents the latest international advances in experimental and clinical research on the physiology, biochemistry, cell biology, and pharmacology of inflammation. Published items include full-length scientific reports, short definitive articles, and papers from meetings and symposia proceedings. The journal's coverage extends to acute and chronic inflammation; mediators of inflammation; mechanisms of tissue injury and cytotoxicity; pharmacology of inflammation; and clinical studies of inflammation and its modification.
Inflammatory Bowel Diseases® brings the most current information in clinical and basic sciences to physicians caring for patients with inflammatory bowel diseases, and investigators performing research in IBD and related fields. .
International Archives of Allergy and Immunology provides a forum for experimental and clinical research in modern molecular and cellular allergology and immunology. Appearing monthly, the journal publishes original work in the fields of allergy, immunopathology, immunogenetics, immunopharmacology, immunoendocrinology, tumor immunology, mucosal immunity, transplantation, and immunology of infectious and connective tissue diseases. In addition to original papers, it features short communications, reviews, mini-reviews, commentaries, and opinions. A team of internationally renowned and committed editors guarantees a fair review process, high scientific quality, and fast dissemination of significant and novel work.